Health minister promised improving pharma IP protection in Russia
This article was originally published in Scrip
Executive Summary
Russia’s ministry of healthcare and social development has demonstrated that it is taking its new responsibility for the protection of pharmaceutical intellectual property seriously by signing a collaboration agreement with the federal service for intellectual property, patents and trademarks. The main objective of the collaboration is to raise the efficiency of IP protection in the pharmaceutical sector. But an industry reaction that has been muted to the point of disinterest indicates that there is a long way to go before the ministry’s move has significant impact. The agreement comes into force with the immediate effect.